Acorai

Acorai delivers radical and disruptive innovation with the world’s first non-invasive device estimating cardiac pressures. It replaces invasive gold-standard tools, improving safety and cost. The product is protected by 7 patent families (3 granted) covering hardware and AI. Time-to-market is late 2026, pending FDA and CE approvals.